Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings

How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis

(2012) Edward J. Mills et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach

(2011) Susanne Schmitz et al.   ANNALS OF THE RHEUMATIC DISEASES

A Dose–Response Meta-Analysis for Quantifying Relative Efficacy of Biologics in Rheumatoid Arthritis

(2011) J W Mandema et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis

(2011) E. Turkstra et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis

(2011) ROBERT LAUNOIS et al.   JOURNAL OF RHEUMATOLOGY

Indirect and mixed treatment comparisons in arthritis research

(2011) A. E. Ades et al.   RHEUMATOLOGY

An overview of models used in economic analyses of biologic therapies for arthritis--from current diversity to future consensus

(2011) J. Madan et al.   RHEUMATOLOGY

Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research

(2011) N. J. Welton et al.   RHEUMATOLOGY

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

(2011) Patricia Guyot et al.   ARTHRITIS RESEARCH & THERAPY

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

(2010) C. Salliot et al.   ANNALS OF THE RHEUMATIC DISEASES

PRISMA Statement

(2010) David Moher et al.   EPIDEMIOLOGY

Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach

(2010) Emily Beth Devine et al.   PHARMACOTHERAPY

Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

(2010) Gert J.D. Bergman et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

(2009) J. A. Singh et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses

(2009) J. P.A. Ioannidis   CANADIAN MEDICAL ASSOCIATION JOURNAL

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal